Today: 9 June 2026
Browse Category

SWX:NESN 16 October 2025 - 8 February 2026

Nestle stock price in focus: France clamps down on baby‑formula toxin as Swiss shares head into new week

Nestle stock price in focus: France clamps down on baby‑formula toxin as Swiss shares head into new week

France lowered its safety threshold for cereulide toxin in infant formula, raising the risk of further product recalls. Nestle shares closed at 73.43 Swiss francs on Friday, down 0.07%, as investors await full-year results on Feb. 19. French authorities are investigating two infant deaths linked to the toxin. Nestle says the affected batches account for less than 0.5% of annual sales.
1 February 2026
·
Nestle stock price: baby-formula death probe and water-unit sale report set up next week

Nestle stock price: baby-formula death probe and water-unit sale report set up next week

Nestlé shares fell 0.98% Friday to 72.47 francs after French officials launched probes into two infant deaths linked to recalled baby formula. French authorities said no scientific link has been established; Nestlé denies any connection. Investors are watching Nestlé’s planned water business stake sale, with first-round bids due this month. Shares dropped about 3.7% over the past week.
24 January 2026
·
Swiss Stock Market Today, November 18, 2025: SMI Slips as Roche Soars, ABB, Zurich and ams-Osram Drag the Index

Swiss Stock Market Today, 21 November 2025: SMI Holds Near Flat as Tech Slides and Defensives Lift Zurich

The Swiss Market Index erased early losses to trade 0.08% higher at 12,553 points by mid-morning Friday, as investors shifted from tech to defensive blue chips. UBS shares fell after a $3 billion buyback, while SGS rose on an acquisition. Nestlé digested a top executive’s retirement, and Schindler’s HR chief exited abruptly. The STOXX 600 dropped 1% amid global tech sell-offs and Fed uncertainty.
21 November 2025
······
McConnell’s Hemp Crackdown Collides With Retail THC Boom: Big Brands, 39 AGs, and Congress Face a ‘Hemp War’ (Nov. 6, 2025)

McConnell’s Hemp Crackdown Collides With Retail THC Boom: Big Brands, 39 AGs, and Congress Face a ‘Hemp War’ (Nov. 6, 2025)

The Consumer Brands Association, representing Coca‑Cola, Nestlé, and others, urged Congress to ban intoxicating hemp products in FY26 spending talks. Thirty-nine state attorneys general renewed calls to tighten hemp’s legal definition. The Senate previously removed a House-backed hemp ban from a key bill, but negotiations continue. Meanwhile, Circle K and Target are expanding hemp-THC beverage sales as states impose new restrictions.
6 November 2025
·····
Nestlé Shares Soar 8% on Surprise Q3 Sales, 16,000-Job Cut Plan – What’s Next?

Nestlé Shocks Investors: 8% Stock Rally After Blowout Q3 and 16,000 Jobs on the Line

Nestlé shares surged 8% on Oct. 16 after Q3 organic sales rose 4.3%, beating forecasts, and real internal growth hit 1.5%. New CEO Philipp Navratil announced 16,000 job cuts over two years and raised the cost-savings target to CHF 3 billion by 2027. The company reaffirmed its 2025 guidance but warned that a strong Swiss franc and U.S. tariffs could pressure profits.
16 October 2025
··

Stock Market Today

  • Nuvalent Shares Surge Near $124 Following GSK's $10.6 Billion Buyout Offer
    June 9, 2026, 10:35 AM EDT. Nuvalent's stock jumped 38.9% to $122.93 after GSK announced a $10.6 billion cash acquisition at $124 per share, reflecting a 40% premium to the last close. The deal highlights GSK's strategic move to expand its oncology portfolio beyond its current 6% share of sales, aiming to capitalize on Nuvalent's two lung cancer drugs pending FDA decisions this year. The tender offer needs the approval of at least half of Nuvalent's Class A shares and U.S. antitrust clearance. Early analyst reactions included target price adjustments but echoed caution over valuation. Nuvalent's pipeline products could face competition from existing ALK-targeted therapies by Pfizer and Roche.

Latest articles

Autozi Shares Jump 400%, Filing Flags Risks for AZI

Autozi Shares Jump 400%, Filing Flags Risks for AZI

9 June 2026
Autozi Internet Technology shares soared over 400% to $5.69 in early Nasdaq trading after a 10-for-1 share consolidation slashed its share count to about 4.49 million, but the surge contrasts with a 63.1% revenue drop, 82.5% plunge in gross profit, and widened net loss, with the company warning of “substantial doubt” about its ability to continue as a going concern.
Redwire Shares Slip After $500 Million Stock Offering Filed

Redwire Shares Slip After $500 Million Stock Offering Filed

9 June 2026
Redwire Corp shares plunged 6.5% to $17.37 after launching a $500 million at-the-market stock program, raising dilution risks for investors as the company seeks flexible funding despite recent record backlog and strong revenue growth; the drop contrasted with gains at other space stocks, highlighting investor concern over potential share issuance.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

9 June 2026
Nuvalent shares soared 38.9% to $122.93, just below GSK’s $124-a-share cash offer after the $10.6 billion buyout was announced, as investors bet on the deal closing with Nuvalent’s two lead lung-cancer drugs already under FDA review and a 40% premium to the last closing price driving the morning’s merger-arb trade.
Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
Go toTop